Results 41 to 50 of about 36,953,089 (284)

Vol 4 Issue 1

Pakistan Journal of Humanities and Social Sciences Research, 2021
S. Soldz
semanticscholar   +2 more sources

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko, Holger N. Lode, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau‐Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Katarzyna Śladowska, Ruth Ladenstein, Paweł Kawalec   +19 more
wiley   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol, Arlene Naranjo, Lulu Chen, Rajen Mody, Steven G. DuBois, Rochelle Bagatell, Navin Pinto   +6 more
wiley   +1 more source

BMT4me En Español: Multisite Feasibility and Usability Testing of a Spanish‐Language mHealth Adherence Support App for Spanish‐Speaking Caregivers of Children After Hematopoietic Stem Cell Transplantation and Cancer Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens, Madeline R. Peek, Bianca Franklin, Emre Sezgin, Melissa Beauchemin   +4 more
wiley   +1 more source

Volume 1, Issue 1

Harvard Kennedy School Misinformation Review, 2020
For the scope of this publication, we use the term “misinformation” to refer to all kinds of false or inaccurate information, independently from the fact that such information was deliberately created and spread to deceive.
Irene Pasquetto
doaj  

AFR volume 93 issue 1 Cover and Front matter

Africa, 2023
Constance Smith, K. Dawson, M. Nielsen, Trisha Phippard, I. Niehaus, Julie Archambault, Maxim Bolt, Karin Barber, Thomas J. Bassett, Heike Becker, Joost Beuving, Keith Breckenridge, Zoe Cormack, Filip De Boeck, Greg Dobler, H. Englund, R. Fardon, J. Fokwang, J. Fontein, Eric Gable, P. Geschiere, Euclides Gonçalves, Danny Hoffman, E. Hull, N. Hunt, E. Hunter, F. Ikanda, Deborah James, M. Janson, F. D. Jong, H. N. Kringelbach, Brian J. Larkin, Derek R. Peterson, David Pratten, K. Pype, Noah Salomon, AbdouMaliq Simone, Benjamin Soares, J. Steinberg, S. Whyte, Alcinda Honwana, Odile Goerg, A. Cutolo, M. Diawara, Andreas Eckert, J. Gewald, Adam T. Jones, O. Kane, Michael Lambek, Elísio Macamo, B. Meyer, M. Nobili, K. Barlow, Philip Burnham, Keren Weitzberg   +54 more
semanticscholar   +1 more source

T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hemophilic arthropathy remains the leading morbidity in hemophilia despite modern prophylaxis, and early joint damage may be missed by routine exams. This study explored T2* MRI as a noninvasive biomarker of hemosiderin deposition in pediatric hemophilia.
Jessica Garcia, Tarique Hussain, Jeanne Dillenbeck, Matthew Hammer, Annette von Drygalski, Guy Young, Ayesha Zia   +6 more
wiley   +1 more source

Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Despite 5‐year survival rates of over 90% among children and adolescents/young adults (CAYAs) with classic Hodgkin lymphoma (cHL), 15%–20% relapse after frontline therapy. Prior analysis of frontline Children's Oncology Group (COG) clinical trials demonstrated that, despite similar rates of relapse, non‐Hispanic Black (NHB) and ...
Mallorie B. Heneghan, Lindsay A. Renfro, Yue Wu, Katia M. Crisler, Erin Marcotte, Tanya Trippett, Terzah Horton, Bradford S. Hoppe, Frank G. Keller, Chris Forlenza, Cindy Schwartz, Kara M. Kelly, Peter D. Cole, Sharon M. Castellino, Justine M. Kahn   +14 more
wiley   +1 more source

TGDK, Volume 2, Issue 1, Complete Issue [PDF]

Transactions on Graph Data and Knowledge
TGDK, Volume 2, Issue 1, Complete ...
doaj   +1 more source

Volume 12 Issue 1(2022)

Professions and Professionalism, 2022
A. Leseth
semanticscholar   +1 more source